Pancreatic Cancer Screening (APRISE Study): Who Should Consider It and Why

Pancreatic cancer is one of the hardest cancers to detect early. Symptoms are often vague, screening is limited, and outcomes can be poor when diagnosis happens late. For people with inherited cancer risk or certain gene variants, the uncertainty can be stressful and confusing.

In this video, Professor Andrew Metz, Director of the Jreissati Pancreatic Centre and Principal Investigator of the APRISE Study (Australian Pancreatic high-RIsk ScrEening Program), explains:

What pancreatic cancer symptoms can look like
The difference between general population risk and inherited risk
Why screening has been so difficult
What the APRISE national screening study is doing
Who may be eligible to participate

Helpful links & contacts:
Learn more about the APRISE program: https://www.inheritedcancers.org.au/i...
Family History Checker from Pankind: http://familychecker.pankind.org.au/
Contact Email: [email protected]
Phone: 0418 370 684

Follow us:
Instagram:   / inheritedcancersaus  
Facebook:   / inheritedcancersaus  
LinkedIn:   / inheritedcancersaus  
Know Your Inherited Cancer Risk: https://www.inheritedcancers.org.au/

#PancreaticCancer #InheritedCancer #CancerScreening #GeneticTesting #BRCA #PALB2 #PancreaticCancerAwareness #APPRISEStudy


0:00 Opening & Introduction
3:18 Why pancreatic cancer is so hard to detect early
5:16 Can pancreatic cancer risk be inherited?
6:40 Lifestyle factors linked to pancreatic cancer
8:17 How common pancreatic cancer is
9:48 General population risk vs inherited gene variants
11:12 Why screening is challenging
13:51 Introducing the APRISE pancreatic screening study
17:01 How to take part, costs and wait times
19:21 How study data is used and international collaboration
21:06 A message for those anxious about their pancreatic cancer risk
23:20 Support from Inherited Cancers Australia and closing